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In an asylum seeker centre in Schleswig-Holstein, 
a resident was diagnosed with furuncle caused by 
a Panton-Valentine leukocidine (PVL)-positive com-
munity-acquired meticillin-resistant Staphylococcus 
aureus (CA-MRSA). As a result of active case find-
ing, 232 of 427 persons (54% of all residents) were 
screened for MRSA and two further PVL-positive 
CA-MRSA cases were identified.
In mid-November 2010, around three weeks after arrival 
at an asylum seeker centre located in Neumünster, cen-
tral reception centre of Schleswig-Holstein, Germany, 
a resident originating from Somalia (case 1) was 
diagnosed with furuncle caused by a PVL-positive 
CA-MRSA. On the same day, the resident was moved 
from a four-bed room to isolation with separate bath-
room and toilet.
Following the identification of this case, we decided 
to perform active case finding and to collect nasal 
swabs from contacts of case 1 and other residents of 
the centre. The objectives of the investigation were to 
identify further cases and to stop possible transmis-
sion of PVL-positive CA-MRSA. We were able to reach 
a high number of residents due to blood collection and 
a vaccination campaign that were taking place at the 
same time in the course of a measles outbreak in the 
centre. In parallel, an intervention plan was developed 
in order to stop possible transmission. Following the 
active case finding, four more CA-MRSA cases were 
identified. Two of these were PVL-positive.
In recent years, emerging community-acquired met-
icillin-resistant Staphylococcus aureus (CA-MRSA) 
infections have become a public health problem, and 
rational strategies for the control of staphylococcal 
colonisation and infections in non-hospital settings 
are required [1]. Compared to the general population, 
close household contacts of the infected person, 
prison inmates, military recruits and children attending 
childcare centres are more frequently colonised with 
CA-MRSA [2-4]. A Swiss study identified non-Swiss/
non European Union citizenship and a history of stay-
ing in a collective housing facility as risk factors for 
CA-MRSA infection [5]. 
The definition of MRSA as CA-MRSA is primarily 
based on epidemiological criteria (e.g. acquired out-
side the hospital setting, lack of risk factors typical 
for infections with hospital-associated MRSA).Cases 
of CA-MRSA are frequently positive for the genes 
encoding the Panton-Valentine leukocidine (PVL), a 
two-component leukolytic toxin associated with skin 
and soft-tissue infections, typically furunculosis [1,4]. 
Although the infection is usually confined to skin and 
soft tissues, systemic complications, including necro-
tising pneumonia, have been reported [1]. Furthermore, 
a number of CA-MRSA represent clonal lineages which 
are different from those of widely disseminated hospi-
tal-associated MRSA.
In the asylum seekers centre described here, residents 
stay from six weeks up to several months, on aver-
age two months, before they are placed in other asy-
lum seekers’ centres in Schleswig-Holstein. The center 
consists of former military barracks and the residents 
are housed in large shared rooms (four to six people) 
and share a bathroom and on average a toilet per eight 
rooms. Upon arrival, each resident receives a hygiene-
package, containing towel, soap, body lotion, tooth-
brush and toothpaste. In the central laundry service, 
everyone can hand over their clothes and towels. Bed 
linen is centrally washed at 75°C with disinfectant. 
Meals are served in a central dining room. 
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Case finding and microbiological 
investigation
For our investigation a case was defined as a person 
residing in the asylum seeker centre during the time of 
the investigation (between 19 and 22 November 2010) 
and who was diagnosed with CA-MRSA by laboratory 
tests. Contacts were defined as persons living in the 
same bedroom or belonging to the same family and 
playing together or having close physical contact with 
the case and residing in the asylum seeker centre dur-
ing the time of the investigation.
Two days after the initial case was identified, we started 
convenience sampling and we collected nasal swabs 
from the contacts of MRSA cases and from the majority 
of those coming to blood collection and/or vaccination. 
In addition, for MRSA cases, swabs were taken from 
the throat, axilla and groin and, where applicable, from 
wounds. The collected samples were sent for diagnos-
tic tests to a private laboratory in Plön and results were 
received on a daily basis. Sterile cotton-tipped swabs 
were used in screening. Plating was on ID-Agar-Plate 
(BioMérieux, Marcy l’Etoile, France). Suspected colo-
nies were tested by agglutination, thus S. aureus was 
confirmed by Slidex Staph Plus® (BioMérieux, Marcy 
l’Etoile, France). If the agglutination test was posi-
tive, oxacillin resistance was tested by PBP2® (Oxoid, 
Basingstoke, Hants, United Kingdom). Samples positive 
Table 3
Demographical information of the PVL-positive CA-MRSA cases and laboratory results, asylum seekers centre, Schleswig-












SPA type, clonal 
complex
Case 1 19 Somalia 23 4 N, T, Ax, W P, A, AS, Ox, Ce, Te, Co lukPV+ t021, CC30
Case 2 4 Serbia 41 6 N P, A, AS, Ox, Ceb lukPV+ etd+ t044, CC80
Case 3 8 Serbia 41 6 N, T P, A, AS, Ox, Ce, Te, F lukPV+ etd+ t044, CC80
A: amoxicillin; AS: ampicillin/sulbactam; Ax: axilla; Ce: cefaclor; Ci: ciprofloxacin; Cl: clindamycin; Co: co-trimoxazole; CA-MRSA: community-
acquired meticillin-resistant Staphylococcus aureus; E: erythromycin; F: fusidic acid; G: gentamicin; L: linezolid; N: nose, Of: ofloxacin; Ox: 
oxacillin; P: penicillin; PVL: Panton-Valentine leukocidine; R: rifampicin; T: throat; Te: tetracycline; Ti: teicoplanin; V: vancomycin; W: wound.
a Days from arrival in the centre until the day of laboratory confirmation of PVL-positive CA-MRSA.
b The resistance pattern is incomplete (F, L, V, Ti were not tested).
Table 2
Cases of CA-MRSA and PVL-positive CA-MRSA cases among asylum seekers, Schleswig-Holstein, Germany, 
November 2010
Country of origin Number of residents
Residents tested CA-MRSA positive cases
PVL-positive CA-MRSA 
cases
Number (%) Number Number
Serbia 74 60 (81) 3 2
The former Yugoslav Republic of Macedonia 44 26 (59) 1 0
Somalia 14 11 (79) 1 1
Other 295 135 (46) 0 0
Total 427 232 (54) 5 3
CA-MRSA: community-acquired meticillin-resistant Staphylococcus aureus; PVL: Panton-Valentine leukocidine.
Table 1
Decolonisation procedures for PVL-positive CA-MRSA cases, asylum seekers centre, Schleswig-Holstein, Germany, 
November 2010
Procedure Specification
•	 Washing skin and hair with octenidin-based solution daily
•	 Application of mupirocin nasal ointment three times daily
•	 Gurgling using 0.1% chlorhexidine solution three times daily
•	 Hand disinfection with an alcohol-based antibacterial hand sanitizer several times daily
•	 Disinfection of personal items (e.g. comb, shaver, glasses, jewellery) with an alcohol-based antimicrobial cleanser daily
•	 Disinfection of bathtub or shower floor and of smooth surfaces with an alcohol-based antimicrobial cleanser daily
•	 Changing and washing (at least at 60°C using a laundry detergent) of towels, bed lines, underwear and clothing daily
•	 Using new toothbrush at each tooth brushing
•	 Using new shoes (with socks) for the decolonisation period
CA-MRSA: community-acquired meticillin-resistant Staphylococcus aureus; PVL: Panton-Valentine leukocidine.
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for MRSA were sent to the German National Reference 
Laboratory for Staphylococci in Wernigerode for further 
characterisation and typing. A multiplex-PCR for the 
presence of genes specific for particular CA-MRSA-
clones was also performed [6]. Nasal swabs were 
collected again from the three PVL-positive CA-MRSA 
cases who had undergone decolonisation procedures 
and were also sent to the private laboratory. 
Information on previous hospitalisations, chronic ill-
nesses and previous use of antibiotics was gathered 
for all MRSA cases.
Intervention for CA-MRSA cases
In order to control further transmission, persons colo-
nised by PVL-positive CA-MRSA had to follow a strin-
gent decolonisation strategy. The decolonisation 
protocol used was based on existing national hospi-
tal-associated MRSA decolonisation measures [7] and 
were agreed on in a teleconference with the partici-
pation of national MRSA experts and the local health 
authority. Non-PVL-positive CA-MRSA cases were not 
entitled for decolonisation at this setting. The meas-
ures were implemented upon receipt of the laboratory 
confirmation for a duration of five days and are sum-
marised in Table 1.
In addition, cases were instructed to enhance hand 
hygiene and to minimise contact with other residents 
of the centre during the five days of the decolonisation 
process. The persons were not allowed to be relocated 
to other centres prior to successful decolonisation.
To determine the success of decolonisation measures, 
nasal swabs were taken from these persons three 
days after the end of the procedure and further swabs 
shall be applied six days and 12 months after decolo-
nisation. In case of a positive sample three days after 
the decolonisation process, decolonisation had to be 
repeated. In case of a positive sample after a second 
decolonisation process, systemic antibiotics should be 
applied. 
Results
At the time of the investigation, 427 residents from 
18 nations were in the centre. The median age was 23 
years (mean age 22.7, SD ±14.1 years) and the male to 
female ratio was 1.5. Samples were collected from 54% 
of the residents (232/427); five persons were positive 
for MRSA. Epidemiological criteria and molecular typ-
ing results revealed them as CA-MRSA. From those, 
PVL-positive CA-MRSA were confirmed in three cases. 
Results on tested persons and laboratory results are 
presented in Table 2. 
PVL-positive CA-MRSA cases
Three PVL-positive CA-MRSA cases were identified. 
Except case 1, no other case had wounds or abscess on 
the skin and none reported a contact with case 1. The 
demographics of the cases and the laboratory results 
are summarised in Table 3. 
A different CA-MRSA strain was identified in each of 
the three cases. The CA-MRSA strain of case 1 was 
assigned to CC30, which is prevalent in South East Asia, 
Oceania, United States of America, United Kingdom, 
Denmark and the Baltic countries. Sporadic cases are 
also described in other European countries [8]. Cases 
2 and 3 (siblings) belonged to the main European clone 
ST80, but the resistance pattern differed. 
All three cases reported previous hospitalisation in 
their home countries: case 1 in 2005 for surgery, case 
2 in 2009 for conservative treatment, case 3 in 2006 
for conservative treatment and in 2008 for surgery. 
None of the cases reported previous use of antibiotics. 
Four other family members living in the same room (for 
cases 2 and 3) and three roommates (for case 1) were 
swabbed and were negative for MRSA. Eight known 
play partners for case 2 and 3 were swabbed and were 
also negative. 
Results of the decolonisation
Nasal swabs were taken from the three treated persons 
three days after decolonisation. For case 3, the swabs 
taken three and six days after the first decolonisation 
were negative, whereas cases 1 and 2 had a negative 
swab three days after repeated decolonisation. For 
the case 1 and 2 we do not have the information about 
the results for the swabs collected after six days. The 
cases were later transferred to other centres and the 
respective authorities were informed about the further 
control tests necessary. 
Discussion
We conducted the investigation and control of cases of 
CA-MRSA in an asylum seeker centre in Germany. In our 
investigation, five cases of CA-MRSA were detected. 
Of those, three were PVL-positive CA-MRSA, however 
all three were different in respect of the resistance 
pattern. Furthermore two isolates were assigned to 
spa-type t044 (siblings, cases 2 and 3), one isolate pre-
sented spa-type t021 (case 1). No transmission in this 
setting was identified. Regarding the siblings (cases 2 
and 3) probably both children were carrying the same 
CA-MRSA ST80 strain, although the resistance profiles 
differed in respect of tetracycline and fusidic acid. 
Genetic studies indicate that the resistance to tetra-
cycline (tetK) and fusidic acid (far1) is located on a 28 
kb plasmid and the loss of this plasmid in case 2 may 
explain the two different resistance profiles.
Although residents live on average with four more per-
sons per room and an average of 40 persons share the 
same bathroom and toilet, these factors apparently did 
not facilitate transmission within the centre. This might 
be related to the fact that the residents only live in the 
centre for a relatively short period (on average two 
months) and that they tend to use personal hygienic 
items and there are no shared towels in bathrooms and 
toilets. 
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Information about the prevalence of CA-MRSA in non-
hospital communities is limited. In healthcare associ-
ated Staphylococcus aureus isolates in Europe, the 
proportion of MRSA varies from below 1% in Northern 
Europe to more than 40% in Malta, Estonia and 
Portugal [9]. In healthcare associated Staphylococcus 
aureus isolates in Serbia, the proportion of MRSA is 
reported as 64% [10]. No published information about 
Somalia was found. 
Outbreaks of skin infections associated with CA-MRSA 
within a defined community have been reported previ-
ously. Several published outbreaks occurred in chil-
dren day care centres, sport teams or among military 
recruits [4]. A furunculous outbreak related to lukS-lukF 
positive Staphylococcus aureus in a German village has 
been successfully terminated with stringent decoloni-
sation procedures [11]. However, re-colonisation has 
been observed within several weeks after successful 
decolonisation in up to 22% of cases [12]. Therefore, 
following up the cases is of great importance. 
Although no further transmission was observed, asy-
lum seeker centres are settings where the appearance 
of PVL-positive CA-MRSA* should be treated with spe-
cial attention and protocols for decolonisation should 
be in place. The control strategy described in our report 
may be helpful for others who have to cope with PVL-
positive CA-MRSA* infections in non-hospital settings.
*Authors’ correction:  
At the request of the authors, the following change was made on 
10 February 2011: ‘CA-MRSA’ was replaced with ‘PVL-positive 
CA-MRSA’ in the last paragraph.
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